These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17768179)

  • 1. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.
    You HJ; Bruinsma MW; How T; Ostrander JH; Blobe GC
    Carcinogenesis; 2007 Dec; 28(12):2491-500. PubMed ID: 17768179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ1-mediated PI3K/Akt and p38 MAP kinase dependent alternative splicing of fibronectin extra domain A in human podocyte culture.
    Madne TH; Dockrell MEC
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):127-135. PubMed ID: 29729706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.
    Hempel N; How T; Cooper SJ; Green TR; Dong M; Copland JA; Wood CG; Blobe GC
    Carcinogenesis; 2008 May; 29(5):905-12. PubMed ID: 18299279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TGFβ1 pathway is required for NFκB dependent gene expression in mouse keratinocytes.
    Hogan KA; Ravindran A; Podolsky MA; Glick AB
    Cytokine; 2013 Dec; 64(3):652-9. PubMed ID: 24075100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
    Ahn JY; Park S; Yun YS; Song JY
    Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
    Walsh MF; Ampasala DR; Hatfield J; Vander Heide R; Suer S; Rishi AK; Basson MD
    Am J Pathol; 2008 Aug; 173(2):385-99. PubMed ID: 18583311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
    Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
    Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta type I receptor/ALK5 contributes to doxazosin-induced apoptosis in H9C2 cells.
    Yang YF; Wu CC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Dec; 380(6):561-7. PubMed ID: 19727674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.
    Chang JZ; Yang WH; Deng YT; Chen HM; Kuo MY
    Clin Oral Investig; 2013 Mar; 17(2):455-61. PubMed ID: 22415218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
    Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
    Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.
    You HJ; How T; Blobe GC
    Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
    McLean S; Di Guglielmo GM
    Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-Derived Growth Factor and Transforming Growth Factor β1 Regulate ARDS-Associated Lung Fibrosis Through Distinct Signaling Pathways.
    Deng X; Jin K; Li Y; Gu W; Liu M; Zhou L
    Cell Physiol Biochem; 2015; 36(3):937-46. PubMed ID: 26088859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
    Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
    J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
    Lee JD; Hempel N; Lee NY; Blobe GC
    Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes.
    Takahashi Y; Maki T; Liang AC; Itoh K; Lok J; Osumi N; Arai K
    Brain Res; 2014 Dec; 1593():1-8. PubMed ID: 25451097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.